Retension Pharmaceuticals, Inc. Common Stock

Net buying: insiders sold $0 and bought $370K of RTSN stock on the open market in the 90 days to Nov 10, 2026, according to SEC Form 4 filings. The largest was Keller, Eric L. (Chief Executive Officer), who bought $250K. The latest filing was on Oct 13, 2026.

None. No member of Congress disclosed a RTSN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

This summary uses filings available on Nov 10, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.